Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks
Seborrheic dermatitis (SD) is a prevalent, chronic relapsing inflammatory skin condition that…
Read MoreLong-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks
A Polyherbal Formulation That Mitigates Cellular Damage in Narrowband UVB-Irradiated HaCaT Cells
Narrowband ultraviolet B (NB-UVB) phototherapy is a commonly used treatment for various…
Evolved to Protect: What Makes Human Skin Remarkable
Skin, the body’s first defense, communicator, and sensory frontier, tells an evolutionary…
Formulation and Evaluation of a Natural Face Serum Utilizing Clitoria Ternatea and Manjistha
The field of cosmetology is increasingly shifting focus towards natural products and…